Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2007

01-11-2007 | Review Article

The Role of Smoking in Crohn’s Disease as Defined by Clinical Variables

Authors: Suhal S. Mahid, Kyle S. Minor, Patrick L. Stevens, Susan Galandiuk

Published in: Digestive Diseases and Sciences | Issue 11/2007

Login to get access

Abstract

The development of Crohn’s disease (CD) is related to an interaction of genetic and environmental factors, with tobacco smoking being one of the most commonly studied environmental factors. In 1998, the Vienna classification was created to define CD by using three accepted clinical variables: age at diagnosis, disease behavior, and disease location. In this qualitative systematic review, articles examining the relationship between smoking and CD, using variables outlined in the Vienna classification, were identified utilizing multiple health databases. Current smoking was found to be associated with late-onset CD (≥40 years old) and current smokers were more likely to progress to stricturing or penetrating type CD than were nonsmoking patients. Conflicting evidence exists regarding the relationship between smoking with respect to CD disease location. The Vienna classification is an important tool in permitting comparisons and predicting clinical course among CD cases, especially when smoking status is taken into account.
Literature
1.
go back to reference Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126(6):1504–1517PubMedCrossRef Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126(6):1504–1517PubMedCrossRef
2.
go back to reference Gasche C, Scholmerich J, Brynskov J, D’Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR (2000) A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6(1):8–15PubMedCrossRef Gasche C, Scholmerich J, Brynskov J, D’Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR (2000) A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6(1):8–15PubMedCrossRef
3.
go back to reference Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, Yzet T, Lerebours E, Dupas JL, Debeugny S, Salomez JL, Cortot A, Colombel JF (2005) Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 54(3):357–363PubMedCrossRef Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, Yzet T, Lerebours E, Dupas JL, Debeugny S, Salomez JL, Cortot A, Colombel JF (2005) Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 54(3):357–363PubMedCrossRef
4.
go back to reference Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B (1988) Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut 29(7):990–996PubMedCrossRef Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B (1988) Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut 29(7):990–996PubMedCrossRef
5.
go back to reference Corrao G, Tragnone A, Caprilli R, Trallori G, Papi C, Andreoli A, Di Paolo M, Riegler G, Rigo GP, Ferrau O, Mansi C, Ingrosso M, Valpiani D(1998) Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Int J Epidemiol 27(3):397–404PubMedCrossRef Corrao G, Tragnone A, Caprilli R, Trallori G, Papi C, Andreoli A, Di Paolo M, Riegler G, Rigo GP, Ferrau O, Mansi C, Ingrosso M, Valpiani D(1998) Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Int J Epidemiol 27(3):397–404PubMedCrossRef
6.
go back to reference Somerville KW, Logan RF, Edmond M, Langman MJ (1984) Smoking and Crohn’s disease. Br Med J (Clin Res Ed) 289(6450):954–956 Somerville KW, Logan RF, Edmond M, Langman MJ (1984) Smoking and Crohn’s disease. Br Med J (Clin Res Ed) 289(6450):954–956
7.
go back to reference Tobin MV, Logan RF, Langman MJ, McConnell RB, Gilmore IT (1989) Cigarette smoking and inflammatory bowel disease. Gastroenterology 93(2):316–321 Tobin MV, Logan RF, Langman MJ, McConnell RB, Gilmore IT (1989) Cigarette smoking and inflammatory bowel disease. Gastroenterology 93(2):316–321
8.
go back to reference Silverstein MD, Lashner BA, Hanauer SB, Evans AA, Kirsner JB (1989) Cigarette smoking in Crohn’s disease. Am J Gastroenterol 84(1):31–33PubMed Silverstein MD, Lashner BA, Hanauer SB, Evans AA, Kirsner JB (1989) Cigarette smoking in Crohn’s disease. Am J Gastroenterol 84(1):31–33PubMed
9.
go back to reference Garcia Rodriguez LA, Gonzalez-Perez A, Johansson S, Wallander MA (2005) Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther 22(4):309–315PubMedCrossRef Garcia Rodriguez LA, Gonzalez-Perez A, Johansson S, Wallander MA (2005) Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther 22(4):309–315PubMedCrossRef
10.
go back to reference Calkins BM (1989) A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34(12):1841–1854PubMedCrossRef Calkins BM (1989) A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34(12):1841–1854PubMedCrossRef
11.
go back to reference Farmer RG, Hawk WA, Turnbull RB Jr (1975) Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology 68:627–635PubMed Farmer RG, Hawk WA, Turnbull RB Jr (1975) Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology 68:627–635PubMed
12.
go back to reference Regueiro M, Kip KE, Cheung O, Hegazi RA, Plevy S (2005) Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis 11(1):42–47PubMedCrossRef Regueiro M, Kip KE, Cheung O, Hegazi RA, Plevy S (2005) Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis 11(1):42–47PubMedCrossRef
13.
go back to reference Lashner BA, Shaheen NJ, Hanauer SB, Kirschner BS (1993) Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children. Am J Gastroenterol 88(3):356–359PubMed Lashner BA, Shaheen NJ, Hanauer SB, Kirschner BS (1993) Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children. Am J Gastroenterol 88(3):356–359PubMed
14.
go back to reference Persson PG, Ahlbom A, Hellers G (1990) Inflammatory bowel disease and tobacco smoke- a case-control study. Gut 31(12):1377–1381PubMedCrossRef Persson PG, Ahlbom A, Hellers G (1990) Inflammatory bowel disease and tobacco smoke- a case-control study. Gut 31(12):1377–1381PubMedCrossRef
15.
go back to reference Franceschi S, Panza E, La Vecchia C, Parazzini F, Decarli A, Bianchi PG (1987) Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol 125(3):445–452PubMed Franceschi S, Panza E, La Vecchia C, Parazzini F, Decarli A, Bianchi PG (1987) Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol 125(3):445–452PubMed
16.
go back to reference Aldhous MC, Drummond HE, Arnott DR, Smith L, Satsangi J (2005) Effect of smoking habit and load on clinical presentation and progression in Crohn’s disease and ulcerative colitis. BSG Abstracts, A2 Aldhous MC, Drummond HE, Arnott DR, Smith L, Satsangi J (2005) Effect of smoking habit and load on clinical presentation and progression in Crohn’s disease and ulcerative colitis. BSG Abstracts, A2
17.
go back to reference Bustamante M, Nos P, Hoyos M, Hinojosa J, Moles JR, Garcia-Herola A, Berenguer J (1998) Relationship between smoking and colonic involvement in inflammatory bowel disease. Rev Esp Enferm Dig 90(12):833–840PubMed Bustamante M, Nos P, Hoyos M, Hinojosa J, Moles JR, Garcia-Herola A, Berenguer J (1998) Relationship between smoking and colonic involvement in inflammatory bowel disease. Rev Esp Enferm Dig 90(12):833–840PubMed
18.
go back to reference Russel MG, Volovics A, Schoon EJ, van Wijlick EH, Logan RF, Shivananda S, Stockbrugger RW (1998) Inflammatory bowel disease: Is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis 4:182–186PubMedCrossRef Russel MG, Volovics A, Schoon EJ, van Wijlick EH, Logan RF, Shivananda S, Stockbrugger RW (1998) Inflammatory bowel disease: Is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis 4:182–186PubMedCrossRef
19.
go back to reference Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP (1996) Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology 110(2):424–431PubMedCrossRef Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP (1996) Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology 110(2):424–431PubMedCrossRef
20.
go back to reference Lindberg E, Jarnerot G, Huitfeldt B (1992) Smoking in Crohn’s disease: effect on localisation and clinical course. Gut 33(6):779–782PubMedCrossRef Lindberg E, Jarnerot G, Huitfeldt B (1992) Smoking in Crohn’s disease: effect on localisation and clinical course. Gut 33(6):779–782PubMedCrossRef
21.
go back to reference Benoni C, Nilsson A (1984) Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 19(6):824–830PubMed Benoni C, Nilsson A (1984) Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 19(6):824–830PubMed
22.
go back to reference Holdstock G, Savage D, Harman M, Wright R (1984) Should patients with inflammatory bowel disease smoke? Br Med J (Clin Res Ed) 288(6414):362CrossRef Holdstock G, Savage D, Harman M, Wright R (1984) Should patients with inflammatory bowel disease smoke? Br Med J (Clin Res Ed) 288(6414):362CrossRef
23.
go back to reference Picco MF, Bayless TM (2003) Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn’s disease. Am J Gastroenterol 98(2):363–368PubMedCrossRef Picco MF, Bayless TM (2003) Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn’s disease. Am J Gastroenterol 98(2):363–368PubMedCrossRef
24.
go back to reference Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, El Yafi F, Colombel JF, Belaiche J (2003) Early development of stricturing or penetrating pattern in Crohn’s disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 52(4):552–557PubMedCrossRef Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, El Yafi F, Colombel JF, Belaiche J (2003) Early development of stricturing or penetrating pattern in Crohn’s disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 52(4):552–557PubMedCrossRef
25.
go back to reference Lautenbach E, Berlin JA, Lichtenstein GR (1998) Risk factors for early postoperative recurrence of Crohn’s disease. Gastroenterology 115(2):259–267PubMedCrossRef Lautenbach E, Berlin JA, Lichtenstein GR (1998) Risk factors for early postoperative recurrence of Crohn’s disease. Gastroenterology 115(2):259–267PubMedCrossRef
26.
go back to reference Rocca G, Astegiano M, Sostegni R, Fiorentini MT, Musso A, Bresso F, Greco S, Ponti V, Demarchi B, Rizzetto M, Pera A (1997) Effect of current smoking on the clinical presentation, medical therapy, and surgical therapy of Crohn’s disease. Gastroenterology 112:A1074 Rocca G, Astegiano M, Sostegni R, Fiorentini MT, Musso A, Bresso F, Greco S, Ponti V, Demarchi B, Rizzetto M, Pera A (1997) Effect of current smoking on the clinical presentation, medical therapy, and surgical therapy of Crohn’s disease. Gastroenterology 112:A1074
27.
go back to reference Breuer-Katschinski BD, Hollander N, Goebell H (1996) Effect of cigarette smoking on the course of Crohn’s disease. Eur J Gastroenterol Hepatol 8(3):225–228PubMedCrossRef Breuer-Katschinski BD, Hollander N, Goebell H (1996) Effect of cigarette smoking on the course of Crohn’s disease. Eur J Gastroenterol Hepatol 8(3):225–228PubMedCrossRef
28.
go back to reference Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8(4):244–250PubMedCrossRef Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8(4):244–250PubMedCrossRef
29.
go back to reference Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J (2001) Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49(6):777–782PubMedCrossRef Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J (2001) Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49(6):777–782PubMedCrossRef
30.
go back to reference Bernell O, Lapidus A, Hellers G (2000) Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann Surg 231(1): 38–45PubMedCrossRef Bernell O, Lapidus A, Hellers G (2000) Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann Surg 231(1): 38–45PubMedCrossRef
31.
go back to reference Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD, Aufses AH Jr (1988) Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut 29(5):588–592PubMedCrossRef Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD, Aufses AH Jr (1988) Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut 29(5):588–592PubMedCrossRef
32.
go back to reference Sachar DB, Andrews HA, Farmer RG, Pallone F, Pena AS, Prantera C, Rutgeerts P (1992) Proposed classification of patient subgroups in Crohn’s disease. Gastroenterol Int 5:141–154 Sachar DB, Andrews HA, Farmer RG, Pallone F, Pena AS, Prantera C, Rutgeerts P (1992) Proposed classification of patient subgroups in Crohn’s disease. Gastroenterol Int 5:141–154
33.
go back to reference Ekbom A, Helmick C, Zack M, Adami HO (1991) The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 100(2):350–358PubMed Ekbom A, Helmick C, Zack M, Adami HO (1991) The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 100(2):350–358PubMed
34.
go back to reference Devlin HB, Datta D, Dellipiani AW (1980) The incidence and prevalence of inflammatory bowel disease in North Tees Health District. World J Surg 4(2):183–193PubMedCrossRef Devlin HB, Datta D, Dellipiani AW (1980) The incidence and prevalence of inflammatory bowel disease in North Tees Health District. World J Surg 4(2):183–193PubMedCrossRef
35.
go back to reference Lee FI, Costello FT (1985) Crohn’s disease in Blackpool—incidence and prevalence 1968–80. Gut 26(3):274–278PubMedCrossRef Lee FI, Costello FT (1985) Crohn’s disease in Blackpool—incidence and prevalence 1968–80. Gut 26(3):274–278PubMedCrossRef
36.
go back to reference Freeman HJ (2005) Age-dependant phenotypic clinical expression of Crohn’s disease. J Clin Gastroenterol 39(9):774–777PubMedCrossRef Freeman HJ (2005) Age-dependant phenotypic clinical expression of Crohn’s disease. J Clin Gastroenterol 39(9):774–777PubMedCrossRef
37.
go back to reference Polito JM, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM (1996) Crohn’s disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111(3):580–586PubMedCrossRef Polito JM, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM (1996) Crohn’s disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111(3):580–586PubMedCrossRef
38.
go back to reference Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH (2003) Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn’s disease phenotypes. Inflamm Bowel Dis 9(5):281–289PubMedCrossRef Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH (2003) Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn’s disease phenotypes. Inflamm Bowel Dis 9(5):281–289PubMedCrossRef
39.
go back to reference Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP, EPWG-IBD Group, EPIMAD Group, GETAID Group (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70(4):845–857PubMedCrossRef Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP, EPWG-IBD Group, EPIMAD Group, GETAID Group (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70(4):845–857PubMedCrossRef
40.
go back to reference CDC (2004) State-specific prevalance of current cigarette smoking among adults: United States, 2003. MMWR 53:1035–1037 CDC (2004) State-specific prevalance of current cigarette smoking among adults: United States, 2003. MMWR 53:1035–1037
41.
go back to reference Jewell T, Robeson S (2004) Smoking during pregnancy: update continuing to place Kentucky’s children at risk. Kentucky Epidemiol NotesRep 39(Nov):1–6 Jewell T, Robeson S (2004) Smoking during pregnancy: update continuing to place Kentucky’s children at risk. Kentucky Epidemiol NotesRep 39(Nov):1–6
42.
go back to reference Mahid SS, Minor KS, Stromberg A, Galandiuk S (in press) Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm Bowel Dis Mahid SS, Minor KS, Stromberg A, Galandiuk S (in press) Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm Bowel Dis
43.
go back to reference Veloso FT, Ferreira JT, Barros L, Almeida S (2001) Clinical outcome of Crohn’s disease: analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis 7(4):306–313PubMedCrossRef Veloso FT, Ferreira JT, Barros L, Almeida S (2001) Clinical outcome of Crohn’s disease: analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis 7(4):306–313PubMedCrossRef
44.
go back to reference Present DH (2005) Management of fistula disease. Inflamm Bowel Dis 4:302–307CrossRef Present DH (2005) Management of fistula disease. Inflamm Bowel Dis 4:302–307CrossRef
Metadata
Title
The Role of Smoking in Crohn’s Disease as Defined by Clinical Variables
Authors
Suhal S. Mahid
Kyle S. Minor
Patrick L. Stevens
Susan Galandiuk
Publication date
01-11-2007
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9624-0

Other articles of this Issue 11/2007

Digestive Diseases and Sciences 11/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.